Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00002369 · ClinicalTrials.gov registry record · NA

A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

A NA study of HIV Infections, sponsored by Bristol-Myers Squibb.

Completed
Registry status
NA
Development phase
200
Enrollment target
11
Study locations

NCT00002369 is a NA study of HIV Infections that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 200 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (55% lower). The trial reports 11 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00002369, a NA study of HIV Infections, has completed, sponsored by Bristol-Myers Squibb.

COMPLETED
Registry status
NA
Development phase
200 participants
Enrollment target
11
Study locations

Study Summary

To evaluate the tolerance, and comparative virologic and immunologic effects of the two combination regimens.

Conditions Studied

HIV Infections

Interventions

  • DRUG Zidovudine
  • DRUG Lamivudine
  • DRUG Indinavir sulfate
  • DRUG Stavudine

Study Locations (11)

Florida

  • HIV Clinical Research Ctr - Fort Lauderdale
  • Infectious Disease Research Institute Inc - Tampa

Massachusetts

  • Boston Univ Med Ctr Hosp / Evans - 556 - Boston
  • Community Research Initiative of New England - Brookline

Other

  • Hosp Regional de Ponce - Area Vieja - Ponce
  • San Juan AIDS Program - Santurce

Alabama

  • Univ of Alabama at Birmingham - Birmingham

Georgia

  • Advance Clinical Research - Atlanta

Louisiana

  • Louisiana State Univ Med Ctr / HIV Outpatient Clinic - New Orleans

Missouri

  • Washington Univ School of Medicine - St Louis

Texas

  • Blackstock Family Health Ctr - Austin

Trial Details

FieldValue
Enrollment Target 200 participants
Phase NA

Sponsor

Bristol-Myers Squibb

1,025 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00002369

The ClinicalTrials.gov registry entry for NCT00002369 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (55% lower). The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 4 interventions - of which Zidovudine is the first listed.

NCT00002369 reports 11 study locations spanning 8 distinct geographic areas - top geographies include Florida, Massachusetts, Other.

Frequently Asked Questions

What is clinical trial NCT00002369 about?

NCT00002369 is a clinical study titled "A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs". To evaluate the tolerance, and comparative virologic and immunologic effects of the two combination regimens.

What is the current status of trial NCT00002369?

This trial is currently completed. It is a NA study. The enrollment target is 200 participants.

What conditions does trial NCT00002369 study?

This clinical trial studies the following conditions: HIV Infections.

What interventions are being tested in trial NCT00002369?

The interventions under investigation include: Zidovudine (DRUG), Lamivudine (DRUG), Indinavir sulfate (DRUG), Stavudine (DRUG).

Who is sponsoring clinical trial NCT00002369?

This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00002369 being conducted?

This trial has 11 study locations across Alabama, Florida, Georgia, Louisiana, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.